CIK 0001561921
- Non-accelerated filer
- Smaller reporting company
TELA Bio, Inc.
Sign in to watch- Ticker
- TELA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455320061
- Phone
- +1 484-320-2930
- Business address
- 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
- Open-market buys, last 90 days
- $167,238
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$167,238. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-13 | Azarbarzin Kurt Director | Conversion · Series B Preferred Stock | −5,377,928 | 0 | ||
| 2019-11-13 | Azarbarzin Kurt Director | Conversion · Series B Preferred Stock | −72,417 | 0 | ||
| 2019-11-13 | Azarbarzin Kurt Director | Conversion · Warrant (right to buy) | −123,653 | 0 | ||
| 2019-11-13 | Azarbarzin Kurt Director | Conversion · Warrant (right to buy) | +123,653 | 123,653 | ||
| 2019-11-13 | Azarbarzin Kurt Director | Conversion · Warrant (right to buy) | −1,665 | 0 | ||
| 2019-11-13 | Azarbarzin Kurt Director | Conversion · Warrant (right to buy) | +1,665 | 1,665 | ||
| 2019-11-13 | PERSENAIRE MAARTEN Chief Medical Officer | Conversion | +7,999 | 66,127 | ||
| 2019-11-13 | PERSENAIRE MAARTEN Chief Medical Officer | Conversion | +12,760 | 78,887 | ||
| 2019-11-13 | PERSENAIRE MAARTEN Chief Medical Officer | Conversion · Series A Preferred Stock | −197,511 | 0 | ||
| 2019-11-13 | PERSENAIRE MAARTEN Chief Medical Officer | Conversion · Series B Preferred Stock | −315,086 | 0 | ||
| 2019-11-13 | PERSENAIRE MAARTEN Chief Medical Officer | Conversion · Warrant (right to buy) | −12,931 | 0 | ||
| 2019-11-13 | PERSENAIRE MAARTEN Chief Medical Officer | Conversion · Warrant (right to buy) | +12,931 | 12,931 | ||
| 2019-11-13 | Greenhalgh Ellis Skott Chief Science Officer | Conversion | +2,025 | 5,623 | ||
| 2019-11-13 | Greenhalgh Ellis Skott Chief Science Officer | Conversion | +4,887 | 10,510 | ||
| 2019-11-13 | Greenhalgh Ellis Skott Chief Science Officer | Conversion · Series A Preferred Stock | −50,000 | 0 | ||
| 2019-11-13 | Greenhalgh Ellis Skott Chief Science Officer | Conversion · Series B Preferred Stock | −120,699 | 0 | ||
| 2019-11-13 | Greenhalgh Ellis Skott Chief Science Officer | Conversion · Warrant (right to buy) | −1,976 | 0 | ||
| 2019-11-13 | Greenhalgh Ellis Skott Chief Science Officer | Conversion · Warrant (right to buy) | +1,976 | 1,976 | ||
| 2019-11-13 | Friedman Ashley Director | Conversion | +59,940 | 106,052 | ||
| 2019-11-13 | Friedman Ashley Director | Conversion | +285,580 | 505,281 |
Page 27 of 29 · 565 trades